InvestorsObserver
×
News Home

Do Analysts Expect Amneal Pharmaceuticals Inc (AMRX) Stock to Rise?

Wednesday, October 21, 2020 11:56 AM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Expect Amneal Pharmaceuticals Inc (AMRX) Stock to Rise?

Analysts who follow Amneal Pharmaceuticals Inc (AMRX) on average expect it to fall -19.00% over the next twelve months. Those same analysts give the stock an average rating of Buy.

That average rating earns the stock an Analyst Ranking of 16, which means it ranks higher than 16 of stocks, based on data compiled by InvestorsObserver.

Overall Score - 3.2
Wall Street analysts are rating AMRX a Buy today. Find out what this means to you and get the rest of the rankings on AMRX!

Why are Analyst Ratings Important?

Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions before a quarterly report that could be worse than expected.

InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.

What's Happening With Amneal Pharmaceuticals Inc Stock Today?

Amneal Pharmaceuticals Inc (AMRX) stock is trading at $5.29 as of 11:44 AM on Wednesday, Oct 21, a rise of $0.08, or 1.54% from the previous closing price of $5.21. The stock has traded between $5.19 and $5.43 so far today. Volume today is low. So far 549,315 shares have traded compared to average volume of 1,073,150 shares.

Click Here to get the full report on Amneal Pharmaceuticals Inc (AMRX) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App